Our findings, coupled with recent literature identifying circulating CD163+ infDC in SLE and urine CD163 as a valuable marker of disease activity in LN, suggest infDCs and their T cell partners may be key contributors to driving the local adaptive immune response during active LN. Here, CD163 is linked to systemic lupus erythematosus.